CRDF - Cardiff Oncology GAAP EPS of -$0.25 beats by $0.01 revenue of $0.11M beats by $0.05M
2023-08-09 17:28:22 ET
- Cardiff Oncology press release ( NASDAQ: CRDF ): Q2 GAAP EPS of -$0.25 beats by $0.01 .
- Revenue of $0.11M (+22.2% Y/Y) beats by $0.05M .
- Cash, cash equivalents, and short-term investments of approximately $89.4 million as of June 30, 2023, projected runway into 2025
For further details see:
Cardiff Oncology GAAP EPS of -$0.25 beats by $0.01, revenue of $0.11M beats by $0.05M